Cargando…
CXCR4-targeted theranostics in oncology
A growing body of literature reports on the upregulation of C-X-C motif chemokine receptor 4 (CXCR4) in a variety of cancer entities, rendering this receptor as suitable target for molecular imaging and endoradiotherapy in a theranostic setting. For instance, the CXCR4-targeting positron emission to...
Autores principales: | Buck, Andreas K., Serfling, Sebastian E., Lindner, Thomas, Hänscheid, Heribert, Schirbel, Andreas, Hahner, Stefanie, Fassnacht, Martin, Einsele, Hermann, Werner, Rudolf A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525349/ https://www.ncbi.nlm.nih.gov/pubmed/35674738 http://dx.doi.org/10.1007/s00259-022-05849-y |
Ejemplares similares
-
Impact of Tumor Burden on Normal Organ Distribution in Patients Imaged with CXCR4-Targeted [(68)Ga]Ga-PentixaFor PET/CT
por: Serfling, Sebastian E., et al.
Publicado: (2022) -
CXCR4-directed theranostics in oncology and inflammation
por: Kircher, Malte, et al.
Publicado: (2018) -
Dual Targeting of Acute Leukemia and Supporting Niche by CXCR4-Directed Theranostics
por: Habringer, Stefan, et al.
Publicado: (2018) -
CXCR4-targeted molecular imaging after severe SARS-Cov-2 infection
por: Lambertini, Alessandro, et al.
Publicado: (2022) -
Theranostics in Hematooncology
por: Buck, Andreas K., et al.
Publicado: (2023)